Influence of age and site of disease on lymph node yield in colorectal cancer

New Zealand Medical Journal

Volumn 127, Issue 1395, 2014, Pages 31-40

  Ahmadi, Omid ^a   Stringer, Mark D ^b,c   Black, Michael A ^c   McCall, John L ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; AGE; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CLINICAL ASSESSMENT; CLINICAL FEATURE; COLORECTAL CANCER; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE YIELD; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; ADENOCARCINOMA; COLON; COLON RESECTION; COLORECTAL TUMOR; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; METHODOLOGY; NEW ZEALAND; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; RADIOTHERAPY; STATISTICS;

ADENOCARCINOMA; AGE FACTORS; AGED; COLECTOMY; COLON; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; NEOADJUVANT THERAPY; NEOPLASM STAGING; NEW ZEALAND; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RADIOTHERAPY; STATISTICS AS TOPIC;

EID: 84907176683     PISSN: 00288446     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. 1. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase Number 10, 2010. Lyon: France, [Updated 19 November 2013; cited 19 November 2013]. Available from: http://globocan.iarc.fr
2. Cunningham D, Atkin W, Lenz HJ, et al. Colorectal cancer. Lancet. 2010;375:1030-47.
3. 3. Ministry of Health. Cancer: New registrations and deaths 2009. Wellington: New Zealand. Ministry of Health; 2012. p. xiii.
4. Gonsalves WI, Kanuri S, Tashi T, et al. Clinicopathologic factors associated with lymph node retrieval in resectable colon cancer: a Veterans' Affairs Central Cancer Registry (VACCR) database analysis. J Surg Oncol. 2011;104:667-71.
5. Bilimoria KY, Stewart AK, Palis BE, et al. Adequacy and importance of lymph node evaluation for colon cancer in the elderly. J Am Coll Surg. 2008;206:247-54.
6. Hong KD, Lee SI, Moon HY. Lymph node ratio as determined by the 7th edition of the American Joint Committee on Cancer staging system predicts survival in stage III colon cancer. J Surg Oncol. 2011;103:406-10.
7. Wright FC, Law CH, Berry S, Smith AJ. Clinically important aspects of lymph node assessment in colon cancer. J Surg Oncol. 2009;99:248-55.
8. Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124:979-94.
9. McGory ML, Shekelle PG, Ko CY. Development of quality indicators for patients undergoing colorectal cancer surgery. J Natl Cancer Inst. 2006;98:1623-33.
10. Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
11. Johnson PM, Porter GA, Ricciardi R, Baxter NN. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol. 2006;24:3570-5.
12. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99:433-41.
13. Vather R, Sammour T, Kahokehr A, et al. Lymph node evaluation and long-term survival in Stage II and Stage III colon cancer: a national study. Ann Surg Oncol. 2009;16:585-93.
14. McDonald JR, Renehan AG, O'Dwyer ST, Haboubi NY. Lymph node harvest in colon and rectal cancer: Current considerations. World J Gastrointest Surg. 2012;4:9-19.
15. Choi HK, Law WL, Poon JT. The optimal number of lymph nodes examined in stage II colorectal cancer and its impact of on outcomes. BMC cancer. 2010;10:267.
16. Chou JF, Row D, Gonen M, et al. Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: a population-based study. Cancer. 2010;116:2560-70.
17. Morris EJ, Maughan NJ, Forman D, Quirke P. Identifying stage III colorectal cancer patients: the influence of the patient, surgeon, and pathologist. J Clin Oncol. 2007;25:2573-9.
18. Shen SS, Haupt BX, Ro JY, et al. Number of lymph nodes examined and associated clinicopathologic factors in colorectal carcinoma. Arch Pathol Lab Med. 2009;133:781-6.
19. Chen HH, Chakravarty KD, Wang JY, et al. Pathological examination of 12 regional lymph nodes and long-term survival in stages I-III colon cancer patients: an analysis of 2,056 consecutive patients in two branches of same institution. Int J Colorectal Dis. 2010;25:1333-41.
20. Parsons HM, Tuttle TM, Kuntz KM, et al. Association between lymph node evaluation for colon cancer and node positivity over the past 20 years. JAMA. 2011;306:1089-97.
21. Khalifa MA, Smith A. Lymph node assessment: issues in pathology. J Surg Oncol. 2009;99:260-4.
22. Ahmadi O, McCall JL, Stringer MD. Does senescence affect lymph node number and morphology? A systematic review. ANZ J Surg. 2013;83:612-8.
23. Gervaz P, Bucher P, Morel P. Two colons-two cancers: paradigm shift and clinical implications. J Surg Oncol. 2004;88:261-6.
24. Wang L, Hollenbeak CS, Stewart DB. Node yield and node involvement in young colon cancer patients: is there a difference in cancer survival based on age?. J Gastrointest Surg. 2010;14:1355-61.
25. Steele SR, Chen SL, Stojadinovic A, et al. The impact of age on quality measure adherence in colon cancer. J Am Coll Surg. 2011;213:95-103.
26. Patel SS, Nelson R, Sanchez J, et al. Elderly patients with colon cancer have unique tumor characteristics and poor survival. Cancer. 2013;119:739-47.
27. Baxter NN, Virnig DJ, Rothenberger DA, et al. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005;97:219-25.
28. Morikawa T, Tanaka N, Kuchiba A, et al. Predictors of lymph node count in colorectal cancer resections: data from US nationwide prospective cohort studies. Arch Surg. 2012;147:715-23.
29. Snaebjornsson P, Jonasson L, Jonsson T, et al. Colon cancer in Iceland--a nationwide comparative study on various pathology parameters with respect to right and left tumor location and patients age. Int J Cancer. 2010;127:2645-53.
30. 30. Yamaji Y, Mitsushima T, Ikuma H, et al. Right-side shift of colorectal adenomas with aging. Gastrointest Endosc. 2006;63:453-8; quiz 64.
31. Hawkins N, Norrie M, Cheong K, et al. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology. 2002;122:1376-87.
32. Vilar E, Gruber SB. Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev Clin Oncol. 2010;7:153-62.
33. Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol. 2005;23:609-18.
34. Guidoboni M, Gafa R, Viel A, et al. Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol. 2001;159:297-304.
35. Kotake K, Honjo S, Sugihara K, et al. Number of lymph nodes retrieved is an important determinant of survival of patients with stage II and stage III colorectal cancer. Jpn J Clin Oncol. 2012;42:29-35.
36. Awwad GE, Tou SI, Rieger NA. Prognostic significane of lymph node yield after long course preoperative radiotherapy in patients with rectal cancer: a systematic review. Colorectal Dis. 2013;15:394-403.
37. Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol. 2001;19:1976-84.
38. Lewis A, Akopian G, Carillo S, Kaufman HS. Lymph node harvest in emergent versus elective colon resections. Am Surg. 2012;78:1049-53.